<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="now growing interest for natural supplements used to control recurrent" exact="migraine" post="headaches. Such approach may increase acceptance and adherence to"/>
 <result pre="(T4: 4.46 + 1.75; p &amp;lt; 0.001 vs T0). The frequency of" exact="migraine" post="attacks was also reduced in the MO group during"/>
 <result pre="the use of nutraceutical in pediatric headache/migraine. Keywords Nutraceuticals Pediatric" exact="migraine" post="Observational study Tanacetum parthenium Prophylaxis Background Migraine is one"/>
 <result pre="to 19 years [ 1]. Migraine is defined as an episodic" exact="pain disorder" post="that can vary from an occasional occurrence to a"/>
 <result pre="loss of school, work, and social activities. As for adults," exact="migraine" post="treatment traditionally includes acute therapy for aborting migraine attacks"/>
 <result pre="for adults, migraine treatment traditionally includes acute therapy for aborting" exact="migraine" post="attacks and prophylactic treatment for reducing the frequency, duration"/>
 <result pre="by patients; in particular, parents ask healthcare professionals to provide" exact="migraine" post="relief for their children. Moreover, even clinicians prefer to"/>
 <result pre="10]. There is now growing interest for natural supplements for" exact="migraine" post="and headache treatment. Due to the low side effects,"/>
 <result pre="natural treatments, in particular nutraceuticals, in the prophylactic treatment of" exact="migraine" post="in children and adolescents, even if the evidences are"/>
 <result pre="furthermore it has antioxidant proprieties. A role of Cq10 in" exact="migraine" post="pathogenesis has been postulated because migraineurs have difficulties in"/>
 <result pre="a multicenter, prospective, observational study in children and adolescents with" exact="migraine" post="(with or without aura) or tension-type headache. From January"/>
 <result pre="study. During the assessment patients reported their age, medical history," exact="migraine" post="family history, headache type and localization. Inclusion criteria were"/>
 <result pre="migraine family history, headache type and localization. Inclusion criteria were" exact="migraine" post="with aura (MA), without aura (MO) or tension-type headache"/>
 <result pre="+ 1.75; p &amp;lt; 0.001 respect to T0). A significant reduction of" exact="migraine" post="frequency was also found for MO group (F(2.740, 131.5);"/>
 <result pre="with Partena was associated with lower intensity of pain for" exact="migraine" post="episodes among pediatric patients suffering from MA and MO."/>
 <result pre="along with anti-nociceptive effects in an animal model of sensory" exact="hypersensitivity" post="associated with migraine) [ 15]. Guidelines of the Società"/>
 <result pre="trigeminovascular system [ 20]. Clinical evidences about the treatment of" exact="migraine" post="are still controversial although the contradictory results may be"/>
 <result pre="about the efficacy of parthenium in the prophylactic treatment of" exact="migraine" post="[ 17, 21]. Studies on Feverfew efficacy in children"/>
 <result pre="21]. Studies on Feverfew efficacy in children and adolescents with" exact="migraine" post="are lacking [ 11]. The other active principles of"/>
 <result pre="and clinical evidences supporting their usefulness in prophylactic treatment of" exact="migraine" post="[ 21]. Several studies revealed decreased levels of the"/>
 <result pre="B2), magnesium (Mg) and CQ10 in plasma and brain of" exact="migraine" post="patients [ 22]. On the other hand, numerous studies"/>
 <result pre="at mitochondrial level, multiple trials have assessed their efficacy in" exact="migraine" post="prevention [ 23– 25]. Riboflavin is a cofactor in"/>
 <result pre="The role of magnesium in the prophylactic treatment of pediatric" exact="migraine" post="is still unclear and high-quality adequately powered trials are"/>
 <result pre="in pediatric population is a continuous challenge for clinicians. Although" exact="migraine" post="in children is phenotypically similar to adult migraine, medications"/>
 <result pre="of the most utilized drugs for prophylactic therapy in pediatric" exact="migraine" post="and there are no significant differences between the high"/>
 <result pre="risk–benefit profile for the use of these therapies in pediatric" exact="migraine" post="prevention [ 9]. On the other hand, our result"/>
 <result pre="frequency and pain intensity in children and adolescences suffering from" exact="migraine" post="and TTH, therefore should be considered as a potential"/>
 <result pre="needed to further assess the effectiveness in nutraceuticals’ use for" exact="migraine" post="treatment in child and adolescent. Abbreviations AAN American Academy"/>
 <result pre="comparative effectiveness meta-analysis of drugs for the prophylaxis of pediatric" exact="migraine" post="headache JAMA Pediatr 2013 167 3 250 258 10.1001/jamapediatrics.2013.508"/>
 <result pre="al. Trial of amitriptyline, topiramate, and place- Bo for pediatric" exact="migraine" post="N Engl J Med 2017 376 2 115 124"/>
 <result pre="Evidence-based guideline update: NSAIDs and other complementary treatments for episodic" exact="migraine" post="prevention in adults: report of the quality standards Subcommittee"/>
 <result pre="paniculata shows anti-nociceptive effects in an animal model of sensory" exact="hypersensitivity" post="associated with migraine Functional Neurology 2016 31 1 53"/>
 <result pre="effects in an animal model of sensory hypersensitivity associated with" exact="migraine" post="Functional Neurology 2016 31 1 53 60 10.11138/FNeur/2016.31.1.053 27027895"/>
 <result pre="inhibits nitroglycerin-induced Fos activation: studies in an animal model of" exact="migraine" post="Cephalalgia: An International Journal of Headache 2005 25 612"/>
 <result pre="O Mauskop A Nutraceuticals in acute and prophylactic treatment of" exact="migraine" post="Curr Treat Options Neurol 2016 18 4 14 10.1007/s11940-016-0398-1"/>
 <result pre="L Agosti RM Schoenen J Efficacy of coenzyme Q10 in" exact="migraine" post="prophylaxis: a randomized controlled trial Neurology. 2005 64 4"/>
 <result pre="Tang PH Pesce AJ Coenzyme Q10 changes are associated with" exact="metabolic syndrome" post="Clin Chim Acta 2004 344 1–2 173 179 10.1016/j.cccn.2004.02.016"/>
 <result pre="A Role of magnesium in the pathogenesis and treatment of" exact="migraine" post="Expert Rev Neurother 2009 9 3 369 379 10.1586/14737175.9.3.369"/>
 <result pre="AD Powers SW Coffey CS et al. Childhood and adolescent" exact="migraine" post="prevention (CHAMP) study: a double-blinded, placebo-controlled, comparative effectiveness study"/>
 <result pre="Topiramate and placebo in the prevention of childhood and adolescent" exact="migraine" post="Headache. 2013 53 5 799 816 10.1111/head.12105 23594025"/>
</results>
